Remove 2019 Remove Individual Remove IT Remove Utilities
article thumbnail

National variation in ASCVD risk between Pooled Cohort Equations and PREVENT [Cardiovascular disease]

Annals of Family Medicine

Context In November 2023, the American Heart Association (AHA) released PREVENT, a new set of risk equations to calculate an individual's risk of atherosclerotic cardiovascular disease (ASCVD). Each individual was separated into clinically significant risk categories of <7.5%, 7.5-10%, Results 3,885 individuals met the criteria.

article thumbnail

In Search for the Antivax Vaccine: Strategical & Ethical Considerations

Integrated Care News by CFHA

Facts on False Beliefs However, research has shown that false beliefs can become even more entrenched when individuals are presented with strong evidence to the contrary. nudges that appeal to reason), individuals can continue to act as responsible agents. They note that if nudges are moderated by reason (i.e.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

Introduction The Collaborative Family Healthcare Association (CFHA) recognizes the utility and potential for Measurement Based Care (MBC) as a core feature of high-quality integrated healthcare. Position Statement on Utilization of Measurement Based Care. MBC is much more than simply administering behavioral health measures.

article thumbnail

Association between obstructive sleep apnea and quality of life in Korean middle-aged people: a cross-sectional study.

Physician's Weekly

This study utilized data from the 8th Korea National Health and Nutrition Examination Survey for 2019 and 2021 to investigate the relationship between OSA and health-related quality of life (HRQoL). After excluding missing values, the analysis included 8,109 adults aged ≥ 40 years. The Author(s).

article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law Blog

In June 2019, Pfizer sought an OIG advisory opinion to ensure that its proposal would not run afoul of federal law. Now, after an unfavorable HHS Office of the Inspector General (OIG) advisory opinion and two defeats in court, Pfizer has appealed the Second Circuit’s decision to the Supreme Court. Background.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Moreover, center patients not only in discussions about individual decision-making but in constructing and drawing meaning from the research. Tsai has seen race-based medicine play out in clinical practice 10:45 What role should race play in making clinical decisions?

Clinic 52
article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

The Guidance provides practical advice for device manufacturers to utilize patient engagement in clinical studies. For additional information on planning patient engagement, please see the CDRH’s Patient Science and Engagement Program. Finally, mark your calendars for the upcoming March 22, 2022 FDA webinar about this Guidance.